Home/Pulmotect/Magnus Höök

MH

Magnus Höök

Co-Founder, Board Director

Therapeutic Areas

Infectious Disease Pulmonology Oncology Supportive Care

Pulmotect Pipeline

Drug	Indication	Phase
PUL-042	Prevention of respiratory infections (viral, bacterial, fungal) in immunocompromised patients	Phase 2

Leadership Team at Pulmotect

Chief Executive Officer

Leo Linbeck III

Chairman of the Board

Atul Varadhachary

View full Pulmotect profile